Search all medical codes

Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu

HCPCS code

HCPCS Procedure: Injection, Rho(D) Immune Globulin (Human), (RhoPhylac), Intramuscular or Intravenous, 100 IU (J2791)

Name of the Procedure:

  • Common Name(s): Rho(D) Immune Globulin Injection, RhoPhylac Injection
  • Technical/Medical Term: Rho(D) Immune Globulin (Human) Administration, intramuscular or intravenous

Summary

Rho(D) immune globulin, commonly known as RhoPhylac, is a blood-derived medication administered either intramuscularly or intravenously. It helps prevent anti-D antibody formation in Rh-negative individuals exposed to Rh-positive blood, which is particularly relevant during pregnancy and childbirth.

Purpose

  • Conditions Addressed:
    • Prevention of Rh sensitization in Rh-negative mothers carrying an Rh-positive fetus.
    • Management of Rh incompatibility.
  • Goals/Expected Outcomes:
    • Prevent the mother's immune system from developing antibodies that could attack Rh-positive blood cells, ensuring safer pregnancies and healthier outcomes for both mother and child.

Indications

  • Specific Symptoms/Conditions:
    • Rh-negative pregnant women (especially after delivery of an Rh-positive baby).
    • Rh-negative individuals exposed to Rh-positive blood through transfusions or organ transplants.
  • Patient Criteria:
    • Confirmed Rh-negative blood type.
    • Potential or actual exposure to Rh-positive blood.

Preparation

  • Pre-procedure Instructions:
    • No specific fasting or dietary restrictions required.
    • Inform the healthcare provider of any medications being taken.
  • Diagnostic Tests/Assessments:
    • Blood typing and screening.
    • Antibody screen to assess for the presence of anti-D antibodies.

Procedure Description

  1. Initial Assessment:
    • Verify patient identity and Rh-negative status.
  2. Preparation:
    • Prepare the injection site (arm or thigh for intramuscular, or vein for intravenous).
  3. Administration:
    • Intramuscular Injection: Administered into the muscle using a syringe.
    • Intravenous Injection: Administered directly into the bloodstream via an IV line.
  4. Monitoring:
    • Observe for immediate allergic reactions or side effects.
  5. Completion:
    • Dispose of medical waste properly and document the procedure in the patient's medical record.

Duration

  • Time: The injection procedure typically takes about 15-30 minutes.

Setting

  • Location: Usually performed in a hospital, outpatient clinic, or a medical office.

Personnel

  • Healthcare Professionals Involved:
    • Nurses or physicians administer the injection.
    • Pharmacists may be involved in the preparation of the medication.

Risks and Complications

  • Common Risks:
    • Mild pain or discomfort at the injection site.
    • Temporary redness or swelling.
  • Rare Risks:
    • Allergic reactions (rash, itching, difficulty breathing).
    • Fever.
    • Elevated blood pressure.
  • Management: Immediate medical intervention for severe allergic reactions.

Benefits

  • Expected Benefits:
    • Effective prevention of Rh sensitization.
    • Reduced risk of hemolytic disease in future pregnancies for Rh-negative women.
  • Onset of Benefits: Protection begins shortly after administration and lasts for several weeks to months, depending on the dosage and individual response.

Recovery

  • Post-procedure Care:
    • Monitor for any adverse reactions for at least 20 minutes after injection.
    • Avoid strenuous activities for several hours.
  • Expected Recovery Time: No significant downtime; normal activities can usually be resumed the same day.
  • Follow-up: Additional doses may be required, especially during pregnancy or after a significant exposure to Rh-positive blood.

Alternatives

  • Other Treatment Options:
    • Regular monitoring and management of Rh sensitization if it occurs.
    • Blood transfusions for the newborn if hemolytic disease develops.
  • Pros and Cons:
    • Rho(D) immune globulin is highly effective but requires timely administration; other options may not be as effective in preventing sensitization.

Patient Experience

  • During the Procedure:
    • Mild to moderate discomfort during the injection.
    • Anxiety or apprehension about the procedure.
  • After the Procedure:
    • Possible soreness at the injection site.
    • General relief knowing the risk of Rh sensitization is minimized.
  • Pain Management:
    • Over-the-counter pain relievers if needed.
    • Applying ice to the injection site to reduce discomfort.

Similar Codes